Login / Signup
Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria.
Öner Özdemir
Ümmügülsüm Dikici
Published in:
Journal of cosmetic dermatology (2022)
Keyphrases
</>
respiratory syndrome coronavirus